United States · FDA National Drug Code directory
Ondansetron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50268-647_47fb3120-1cb0-55b8-e063-6394a90a662a
- Product NDC
- 50268-647
- Form
- SOLUTION
- Composition / generic term
- Ondansetron
- Labeler
- AvPAK
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230920
- Source listing expiry
- 20271231
Source-listed ingredients
- ONDANSETRON HYDROCHLORIDE — 4 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 40 CUP, UNIT-DOSE in 1 TRAY (50268-647-14) / 5 mL in 1 CUP, UNIT-DOSE (50268-647-11) · 50268-647-14
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →